Bundamedik Tbk vs Satyamitra Kemas Lestari Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Satyamitra Kemas Lestari Tbk. trades at Rp139 (market cap 468.28B, 80.1K 24h volume). The key difference: Bundamedik Tbk is far larger — about 3.2× Satyamitra Kemas Lestari Tbk.'s market cap, and Bundamedik Tbk is more actively traded (536.7K versus 80.1K). Which is the better fit depends on your goals.
| BMHS | SMKL | |
|---|---|---|
Market Cap | 1.51T | 468.28B |
Volume | 536.7K | 80.1K |
Lot | 5.37K | 801 |
Turnover | 93.41M | 11.05M |
Average Price | 174.05 | 137.94 |
Value | 93.41M | 11.05M |
Indicative Equilibrium Price | 176 | 139 |
Indicative Equilibrium Volume | 100 | 29 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →PT Satyamitra Kemas Lestari Tbk (The Company) was established based on Deed of Establishment No. 12 dated July 26, 2001 which was made in the presence of Juniaty Tedjaputra, S.H., a notary in Tangerang.
Read more on SMKL →